We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

48 hedge funds and large institutions have $23.4M invested in Infinity Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

2% more funds holding

Funds holding: 47 → 48 (+1)

14% less capital invested

Capital invested by funds: $27.2M → $23.4M (-$3.82M)

46% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 13

Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
13
Closed
3
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$30K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$147K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$145K
3
Victory Capital Management
Victory Capital Management
Texas
+$21.7K
4
Ameriprise
Ameriprise
Minnesota
+$16.4K
5
Group One Trading
Group One Trading
Illinois
+$10.5K

Top Sellers

Rank Fund Capital Flow
1
PIM
Platinum Investment Management
Australia
-$252K
2
OAM
Oxford Asset Management
United Kingdom
-$235K
3
BCM
Bridgeway Capital Management
Texas
-$101K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$51.9K
5
Citadel Advisors
Citadel Advisors
Florida
-$33.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$14.6M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.94M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$1.16M +$147K +127,101 +10%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$830K – – –
BlackRock
5
BlackRock
New York
$810K -$2.49K -2,150 -0.2%
PIM
6
Platinum Investment Management
Australia
$771K -$252K -217,353 -19%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$493K -$51.9K -44,736 -7%
BBA
8
Baker Bros. Advisors
New York
$486K – – –
BL
9
Bleichroeder LP
New York
$419K – – –
BCM
10
Bridgeway Capital Management
Texas
$343K -$101K -86,900 -17%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$304K – – –
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$222K +$145K +125,096 +90%
Northern Trust
13
Northern Trust
Illinois
$146K -$388 -335 -0.2%
QI
14
QS Investors
New York
$127K – – –
EWM
15
Evercore Wealth Management
New York
$120K – – –
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$101K – – –
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$74K – – –
Bank of New York Mellon
18
Bank of New York Mellon
New York
$58K -$479 -413 -0.6%
NC
19
NewSquare Capital
Pennsylvania
$58K – – –
State Street
20
State Street
Massachusetts
$46K – – –
CHAM
21
Clear Harbor Asset Management
Connecticut
$27K +$1.65K +1,425 +5%
Charles Schwab
22
Charles Schwab
California
$26K – – –
Russell Investments Group
23
Russell Investments Group
United Kingdom
$21K -$2.09K -1,800 -6%
SC
24
Savant Capital
Illinois
$21K – – –
CB
25
Community Bank
New York
$20K – – –
1
2

INFI Hedge Fund Activity: Q1 2020 in Review

48 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2020, worth a combined $23.4M — down 14% from $27.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new INFI positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 13 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $147K. The largest seller was Platinum Investment Management, cutting an estimated $252K.

  • 48 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2020, up from 47 in Q4 2019.
  • Funds reported $23.4M of Infinity Pharmaceuticals, Inc. stock for Q1 2020, down 14% quarter-over-quarter.
  • 6 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2020 and 3 closed out, a net change of +3 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2020 was Renaissance Technologies, an estimated $147K added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q1 2020 was Platinum Investment Management, an estimated $252K sold.

Based on aggregated 13F filings for Q1 2020.